Darunavir CAS 206361-99-1 Anti-HIV Puritas ≥99.0% API Alta Puritas HIV Protease Inhibitor
| Nomen chemicum | Darunavir |
| Synonyma | TMC114;UIC-94017 |
| CAS Number | 206361-99-1 |
| CATTUS Number | RF-API68 |
| Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
| Formulae hypotheticae | C27H37N3O7S |
| M. Pondus | 547.66 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba vel Off-White Crystalline pulveris |
| Lepidium sativum | MS/HNMR HPLC |
| Solubilitas | Solutum in DMSO, leviter solutum in aqua |
| Liquescens punctum | 74.0~76.0℃ |
| Lepidium sativum | 1H NMR |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) |
| Substantiae cognatae | |
| Max Single immunitas | ≤0.30% |
| Totalis immunditias | ≤1.0% |
| RELICTUM Solvents | Ethanol ≤0.30% |
| Damnum in Siccatio | ≤0.50% |
| Residere in Ignition | ≤0.10% |
| Metalla gravis | ≤20ppm |
| Arsenicum | ≤1.5ppm |
| Test Standard | Enterprise Standard |
| Consuetudinem | Darunavir (CAS 206361-99-1) HIV-1 Protease Inhibitor Anti-HIV |
sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Darunavir (nomen notam Prezista, olim TMC114 notum), est protease inhibitor medicamentorum usus infectio HIV tractantium.Darunavir est optio curatio OARAC commendatae pro adultis et adolescentibus peritia tractandis et simplicibus et tractandis.Darunavir novum genus peptidis anti protease inhibitores retrovirales in AIDS therapia est.Primum a Johnson pharmaceutica Islandiae ramo, Tibotec evoluta est.Est summae bioavailability in 6 protease inhibitores (saquinavir, ritonavirvir, indinavir, naphthalene nelfinavir, amprenavir et ABT378/r).Agit claudendo formationem novarum ac maturarum virium particularum e superficie cellarum hospitii infectae et tutelam viri inhibendo.Cum productum diu adhibitum est, plerumque HIV vectorem in sanguinem reducere potest, comitem CD4 cellularum augere, casum infectio HIV minuere, qualitatem vitae prorogare et vitam augere.Adultis qui HIV viro infectis convenit, sed usum medicamentorum antiretroviralium exsistentium nullum effectum habent.Medicamentum componi debet cum usu bibulae ritonavirorum vel aliorum antiretroviralium humilium ad efficaciam emendandam.Actio antiviralis in vitro aestimari potest, cum contra lymphocytes et lymphocytes in sanguine peripherico acuta et chronica infecta.
